Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain

被引:53
|
作者
Petzold, Axel
Shaw, Gerry
机构
[1] UCL, Dept Neuroimmunol, Inst Neurol, London WC1N 3BG, England
[2] Univ Florida, Coll Med, Dept Neurosci, Evelyn F & William L McKnight Brain Inst, Gainesville, FL 32611 USA
关键词
neurofilament; NfH; NF-H; pNfH; biomarker;
D O I
10.1016/j.jim.2006.09.021
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Recent studies suggest that the quantification of neurofilament subunits in cerebrospinal fluid (CSF), blood and amniotic fluid may reflect neuroaxonal damage and be of high clinical value. The present study aims to cross-validate two different independently developed ELISA techniques for the quantification of the phosphorylated axonal forms of the neurofilament heavy chain (pNfH). Methods: The London ELISA method is based on barbitone buffer and the commercially available SM135 capture antibody. The Gainesville method uses Tris-buffered saline (TBS) and an affinity purified chicken polyclonal capture antibody (C-pNfH). Coded CSF from 50 patients with neurological diseases were analyzed in duplicate by both laboratories, each using both ELISA methods, but with each lab using their own detection antibody, tertiary antibody and chromogen. Methods were compared using Bland Altman plots. Correlation and regression analyses were used to allow for transformation of values between both methods. Results: The Bland-Altman plots demonstrated that 96% of all samples fell into the narrow 95% limits of agreement (0.04 units of OD). There was a high correlation (Spearman R = 0.92, p < 0.0001 and Pearson R = 0.98, p < 0.0001) between the Gainesville (1) and the London (X) method with Y=0.132+1.104*X. The previously determined upper reference limit of 0.73 mg/l (London method) corresponds to 0.94 mg/l for the Gainesville method. CSF pNfH levels above the reference limit were observed in patients with encephalitis, encephalomyelitis, hydrocephalus, subarachnoid haemorrhage, spino-muscular atrophy, stroke and cancer with both methods agreeing in all cases. Conclusion: The two assays are in excellent agreement, suggesting that pNfH, which has a number of unusual protein chemical features, may be the biomarker of choice for the routine and robust detection of axonal injury and degeneration in both research and clinical contexts. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 50 条
  • [21] Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON)
    Guy, John
    Shaw, Gerry
    Ross-Cisneros, Fred N.
    Quiros, Peter
    Salomao, Solange R.
    Berezovsky, Adriana
    Carelli, Valerio
    Feuer, William J.
    Sadun, Alfredo A.
    MOLECULAR VISION, 2008, 14 (281): : 2443 - 2450
  • [22] Comparison of Two Methods for Determination of NGAL Levels in Urine: ELISA and CMIA
    Krzeminska, E.
    Wyczalkowska-Tomasik, A.
    Korytowska, N.
    Paczek, L.
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2016, 30 (06) : 956 - 960
  • [23] Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease
    Yuri Matteo Falzone
    Teuta Domi
    Federica Agosta
    Laura Pozzi
    Paride Schito
    Raffaella Fazio
    Ubaldo Del Carro
    Alessandra Barbieri
    Mauro Comola
    Letizia Leocani
    Giancarlo Comi
    Paola Carrera
    Massimo Filippi
    Angelo Quattrini
    Nilo Riva
    Journal of Neurology, 2020, 267 : 2272 - 2280
  • [24] Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease
    Falzone, Yuri Matteo
    Domi, Teuta
    Agosta, Federica
    Pozzi, Laura
    Schito, Paride
    Fazio, Raffaella
    Del Carro, Ubaldo
    Barbieri, Alessandra
    Comola, Mauro
    Leocani, Letizia
    Comi, Giancarlo
    Carrera, Paola
    Filippi, Massimo
    Quattrini, Angelo
    Riva, Nilo
    JOURNAL OF NEUROLOGY, 2020, 267 (08) : 2272 - 2280
  • [25] Increased CSF Levels of Phosphorylated Neurofilament Heavy Protein following Bout in Amateur Boxers
    Neselius, Sanna
    Zetterberg, Henrik
    Blennow, Kaj
    Marcusson, Jan
    Brisby, Helena
    PLOS ONE, 2013, 8 (11):
  • [26] Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy
    Toedebusch, C. M.
    Bachrach, M. D.
    Garcia, V. B.
    Johnson, G. C.
    Katz, M. L.
    Shaw, G.
    Coates, J. R.
    Garcia, M. L.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2017, 31 (02): : 513 - 520
  • [27] Two Cases of Isolated Neurofilament Heavy Chain Antibody Syndrome
    Mirzoev, Alexander
    NEUROLOGY, 2022, 99 (23) : S54 - S54
  • [28] High CSF-neurofilament heavy chain levels in neuromyelitis optica
    Nakashima, Ichiro
    Miyazawa, Isabelle
    Petzold, Axel
    Fujihara, Kazuo
    Sato, Shigeru
    Misu, Tatsuro
    Takahashi, Toshiyuki
    Nakamura, Masashi
    Watanabe, Shohei
    Itoyama, Yasuto
    NEUROLOGY, 2007, 68 (12) : A161 - A161
  • [29] Association between plasma phosphorylated neurofilament heavy chain and efficacy endpoints in the nusinersen NURTURE study
    Muntoni, F.
    Sumner, C.
    Darras, B.
    Crawford, T.
    Finkel, R.
    Mercuri, E.
    De Vivo, D.
    Oskoui, M.
    Tizzano, E.
    Ryan, M.
    Liu, Y.
    Petrillo, M.
    Stebbins, C.
    Koenig, E.
    Fradette, S.
    Farwell, W.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S146 - S146
  • [30] Association Between Plasma Phosphorylated Neurofilament Heavy Chain and Efficacy Endpoints in the Nusinersen NURTURE Study
    Finkel, R.
    Sumner, C.
    Darras, B.
    Muntoni, F.
    Crawford, T.
    Mercuri, E.
    De Vivo, D.
    Oskoui, M.
    Tizzano, E.
    Ryan, M.
    Liu, Y.
    Petrillo, M.
    Stebbins, C.
    Koenig, E.
    Fradette, S.
    Farwell, W.
    ANNALS OF NEUROLOGY, 2019, 86 : S122 - S122